Investors

MEI Pharma (Nasdaq: MEIP) is a San Diego-based late-stage pharmaceutical company focused on building a leading oncology franchise. Our portfolio of drug candidates contains four clinical-stage candidates, including one candidate in an ongoing Phase 3 global registration trial and another candidate that is entering a clinical study to support an accelerated approval marketing application with the U.S. Food and Drug administration.